-
1
-
2
Cancer Vaccines and Beyond: The Transformative Role of Nanotechnology in Immunotherapy
Published 2025-02-01Subjects: Get full text
Article -
3
Multi-omics and AI-driven immune subtyping to optimize neoantigen-based vaccines for colorectal cancer
Published 2025-06-01Subjects: Get full text
Article -
4
Melanoma antigens in pediatric medulloblastoma contribute to tumor heterogeneity and species-specificity of group 3 tumors
Published 2025-07-01Subjects: Get full text
Article -
5
Autoantibodies against tumor-associated antigens as one class of serological markers
Published 2019-04-01Subjects: “…tumor antigens…”
Get full text
Article -
6
The Potential Use of Digital Twin Technology for Advancing CAR-T Cell Therapy
Published 2025-04-01Subjects: Get full text
Article -
7
Immunophenotyping of colon cancer for identification of potential antigens for colon cancer vaccines
Published 2025-04-01Subjects: Get full text
Article -
8
Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies
Published 2024-12-01Subjects: Get full text
Article -
9
Patient-specific dendritic cell vaccines with autologous tumor antigens in 72 patients with metastatic melanoma
Published 2019-06-01Subjects: “…autologous tumor antigens…”
Get full text
Article -
10
-
11
Enhancing breast Cancer immunotherapy using gold nanoparticles carrying tumor antigens
Published 2025-05-01Subjects: Get full text
Article -
12
-
13
Adoptive immune cell therapy for colorectal cancer
Published 2025-04-01Subjects: Get full text
Article -
14
Cancer Vaccines: A Promising Therapeutic Strategy in Advanced Solid Tumors
Published 2025-05-01Subjects: Get full text
Article -
15
Cancer vaccines: current status and future directions
Published 2025-02-01Subjects: Get full text
Article -
16
The SV40 virus enhancer functions as a somatic hypermutation-targeting element with potential tumorigenic activity
Published 2024-12-01Subjects: Get full text
Article -
17